Semi-rigid dopamine analogs reveal distinct conformational needs for vascular receptor interactions. A-6,7-DTN analogs activate dopamine receptors, while A-5,6-DTN analogs target beta2-adrenergic receptors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: